It provides strategies; Marketers and senior executives with the critical information they need to assess the global artificial intelligence (AI) in drug discovery market amid the COVID-19 shutdown.
NEW YORK, June 29, 2023 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Artificial Intelligence (AI) in Drug Discovery Global Market Opportunities and Strategies to 2032” – https://www.reportlinker.com/ p06471582/ ?utm_source=GNW
press release –
Where is the biggest and fastest growing artificial intelligence (AI) market in drug discovery? How does the market relate to the overall economy; Demographics and other similar markets? What forces will shape the market in the future? Artificial Intelligence (AI) in the drug discovery market answers all these questions and many more.
The report covers market characteristics; size and growth; division regional and national breakdowns; Competitive landscape; market share; Trends and strategies for this market tracks the market’s historical and forecast market growth by geography.
It places the market within the broader context of artificial intelligence (AI) in the drug discovery market. And it compares with other markets.
The report covers the following chapters:
• Introduction and market characteristics
A brief introduction to the segments involved in the market, definitions and explanations of artificial intelligence (AI) in the drug discovery market.
• Key trends
It highlights key trends shaping the global artificial intelligence (AI) in drug discovery market. This section also highlights future developments in the market.
• Global market size and growth
Global historic (2017-2022) and forecast (2022-2027) and (2027-2032) market values, and the drivers and restraints supporting and controlling market growth over the historic and forecast periods.
• Regional analysis
Historic (2017-2022) and forecast (2022-2027) and (2027-2032) market values and growth and market share comparison by region.
• Market segmentation
It contains market values (2017-2032) and analysis by technology, drug type, treatment type and segment analysis by end-user in the market.
• Regional market size and growth
Regional market size (2022), historical (2017-2022) and forecast (2022-2027) and (2027-2032) market values, and growth and market share comparisons by countries in the region. This report includes information on all major countries in Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and each region.
• Competitive landscape
Details on the competitive landscape of the market, estimated market share and company profiles of leading players.
• Key mergers and acquisitions
Information on recent mergers and acquisitions in the market. This section provides key financial details of mergers and acquisitions that have shaped the market in recent years.
• Market opportunities and strategies
It describes market opportunities and strategies based on research findings, contains information about growth opportunities, segments and strategies to pursue in those markets.
• Conclusions and recommendations
This section includes recommendations for artificial intelligence (AI) for drug discovery vendors regarding geographic expansion of product/service offerings, marketing strategies, and target groups.
• Appendix
This section includes details on the NAICS codes, abbreviations, and currency codes included in this report.
Scope:
Markets Covered:
1) In technology: context-aware processing; natural language processing; Method of inquiry: Deep learning
2) by drug type: small molecules; Large molecules
3) by type of treatment: metabolic disease; Cardiovascular disease: oncology; Neurodegenerative diseases; Anti-infectious diseases: Respiratory diseases: Other treatment methods
4) By end user: pharmaceutical companies; Biopharmaceutical companies; Academic and Research Institutions; Other end users
Companies mentioned: IBM Corporation; Microsoft Corporation; NVIDIA Corporation; Exscientia; alphabet Atomwise Inc.
Countries: China; Australia; India; Indonesia; Japan; South Korea; America; Brazil; France; Germany; UK; Russia.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; south america; middle east; Africa.
Time series: Five years historical and ten years forecast.
Data: market size and growth ratios of related markets; GDP: Per capita spending; Comparison of Artificial Intelligence (AI) in Drug Discovery Indicators.
Data components: Country and regional historical and forecast data; Market share of competitors; Market segments.
Source and Reference: The information and analysis in the report is derived using endnotes.
Reasons to buy
• Get a truly global view of this market with an extremely comprehensive report covering 12 geographies.
• Understand whether the market is being affected by the corona virus and how it can emerge and grow as the virus’s impact diminishes.
• Creating regional and country strategies based on local data and analysis.
• Identify growth areas for investment.
• Outperform competitors by leveraging forecasting data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Use relationships between key data sets for advanced strategy.
• Suitable for supporting internal and external presentations with reliable high quality data and analysis
Read the full report: https://www.reportlinker.com/p06471582/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker organizes the latest industry data so you can find all the market research you need – instantly, in one place.
_______________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
[ad_2]